CORNING PHARMACEUTICAL SERVICES INC
Other · SEC filings ↗ · Compare ⊕
Financials
SEC XBRL · annual| FY13 | FY12 | FY11 | FY10 | FY09 | FY08 | |
|---|---|---|---|---|---|---|
| Revenue | $634.3M | $573.9M | $2.24B | $2.04B | $1.96B | $1.83B |
| Operating income | $48.3M | $46.1M | $180.6M | $47.5M | $228.6M | $263.6M |
| Net income | $48.2M | $35.7M | $132.2M | $68.3M | $175.9M | $196.8M |
| Total assets | $2.56B | $2.29B | $2.11B | $1.97B | $1.97B | $1.75B |
| Total liabilities | $991.3M | $981.1M | $650.2M | $685.7M | $563.9M | $558.2M |
| Equity | $1.57B | $1.31B | $1.46B | $1.28B | $1.41B | $1.19B |
| EPS (diluted) | $0.86 | $0.60 | $2.16 | $1.06 | $2.73 | $3.08 |
| Shares out. | 55.1M | 58.5M | 60.4M | 64.2M | 64.3M | 64.0M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2013- Operating margin
- 7.6%
- Net margin
- 7.6%
- Return on equity
- 3.1%
- Return on assets
- 1.9%
- Return on capital (ROCE)
- 2.5%
- Liabilities / assets
- 38.8%
- Debt / equity
- 0.63×
- Book value / share
- $28.40
- Revenue growth (YoY)
- 10.5%
- Net income growth (YoY)
- 34.9%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2013- Altman Z″ (distress)
- 6.29safe
- Accruals / assets
- −14.0%clean
- Piotroski F-Score
- 7/9strong
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 6 good- Operating margin is positive
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Material events
SEC Form 8-K · most recent- Terminated a material agreement · Completed an acquisition or disposition · Debt acceleration / triggering event · Delisting / listing-standard notice · Modified shareholder rights · Change in control · Director / officer change · Amended charter or bylawsFeb 19, 2015
- Shareholder vote · Other material eventFeb 18, 2015
- Other material eventFeb 9, 2015
- Results of operationsFeb 4, 2015
- Other material eventJan 12, 2015
- Entered a material agreement · Other material eventNov 4, 2014
- Results of operationsNov 3, 2014
- Results of operationsJul 30, 2014
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.